Ticagrelor improves systemic immune-inflammation index in acute coronary syndrome patients.
Mehmet Koray AdaliIpek BuberOguz KilicAnil TurkozSamet YilmazPublished in: Acta cardiologica (2021)
NLR, MHR, PLR, and SII levels were lower in ACS patients treating with ticagrelor. Ticagrelor may improve these inflammatory parameters in percutaneous coronary intervention (PCI)-treated ACS patients compared to clopidogrel.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- end stage renal disease
- st segment elevation myocardial infarction
- newly diagnosed
- ejection fraction
- st elevation myocardial infarction
- acute myocardial infarction
- oxidative stress
- coronary artery disease
- coronary artery bypass grafting
- heart failure
- coronary artery bypass